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Background: Up to 85% of hospital in-patients will require some form of vascular access
device to deliver essential ﬂuids, drug therapy, nutrition and blood products, or facilitate
sampling. The failure rate of these devices is unacceptably high, with 20–69% of peripheral
intravenous catheters and 15–66% of central venous catheters failing due to occlusion,
depending on the device, setting and population. A range of strategies have been
developed to maintain device patency, including intermittent ﬂushing. However, there is
limited evidence informing ﬂushing practice and little is known about the current ﬂushing
practices.
Objective: The aim of the study was to improve our understanding of current ﬂushing
practices for vascular access devices through a survey of practice.
Method: A cross-sectional survey of nurses and midwives working in the State of
Queensland, Australia was conducted using a 25-item electronic survey that was
distributed via the local union membership database.
Results: A total of 1178 surveys were completed and analysed, with n = 1068 reporting
peripheral device ﬂushing and n = 584 reporting central device ﬂushing. The majority of
respondents were registered nurses (55%) caring for adult patients (63%). A large
proportion of respondents (72% for peripheral, 742/1028; 80% for central, 451/566) were
aware of their facility’s policy for vascular access device ﬂushing. Most nurses reported
using sodium chloride 0.9% for ﬂushing both peripheral (96%, 987/1028) and central
devices (75%, 423/566). Some concentration of heparin saline was used by 25% of those
ﬂushing central devices. A 10-mL syringe was used by most respondents for ﬂushing;
however, 24% of respondents used smaller syringes in the peripheral device group. Use of
preﬁlled syringes (either commercially prepared sterile or preﬁlled in the workplace) was
limited to 10% and 11% respectively for each group. The frequency of ﬂushing varied
widely, with the most common response being pro re nata (23% peripheral and 21%
central), or 6 hourly (23% peripheral and 22% central). Approximately half of respondents
stated that there was no medical order or documentation for either peripheral or central
device ﬂushing.
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 Approximately 85% of all hospitalised patients will
require some form of intravenous therapy.
 Vascular access device occlusion ranges from 15 to 69%
depending on device and setting, with associated costs to
the patient, organisation and healthcare system.
 There is a paucity of research and a high degree of
practice variation in the maintenance of peripheral and
central venous device patency, including the role of
ﬂushing to prevent complications.
hat this paper adds
 The results of this study have clariﬁed nursing and
midwifery practice related to vascular access device
ﬂushing.
 The results further highlight the inconsistencies in
ﬂushing practice and the need for evidence in this area.
 The results have laid the foundation for an informed
protocol development for future intervention and
randomised controlled trial work in vascular access
device patency and ﬂushing practice.
. Introduction and background
Venous access via peripheral and central venous
atheters is frequently used in hospital care to administer
uids, drugs, blood and nutrition, and to withdraw blood
r testing, among other purposes. These devices may need
 be left in place for days or even weeks; but they are
ssociated with complications that can be mechanical or
fectious. Mechanical complications include occlusion,
rombosis, dislodgement, inﬁltration, leakage, phlebitis
nd scar formation. Infectious complications include
acterial or fungal sepsis. Thrombosis or phlebitis at the
atheter site can act as a focus for nosocomial infection that
 associated with extended admission time, additional
osts and increased mortality (Maki et al., 2006; Maki and
inger, 1991; Mermel et al., 2009).
Each year, approximately 450,000 individuals are
dmitted to Queensland public hospitals (Australian
ureau of Statistics, 2013). The majority require intrave-
ous catheterisation for the administration of medications
r ﬂuid. Based upon this, it is estimated that 150,000 will
eed a peripheral intravenous catheter in place for more
an three days (Tuffaha et al., 2014). A survey from
003 stated the proportion of central venous catheter use
is approximately 29% of the general hospital population,
rising up to 80% for patients in critical care settings (Climo
et al., 2003). There have been a range of strategies to
prevent or reduce intravenous catheter related complica-
tions. These include: optimising patency through continu-
ous infusion or intermittent ﬂushes with either normal
saline, heparin, antibiotic and/or ethanol locks (Goode
et al., 1991; Peterson and Kirchhoff, 1991; Randolph et al.,
1998); less frequent catheter and infusion set changes
(Bregenzer et al., 1998; Cornely et al., 2002; Homer and
Holmes, 1998; Rickard et al., 2012; White, 2001);
placement of in-line ﬁlters (Chee and Tan, 2002; Roberts
et al., 1994); and designated intravenous therapy teams
(da Silva et al., 2010; Wenzel and Edmond, 2006). Despite
these interventions, catheter failure before the end of
treatment is all too common. The failure rate of peripheral
intravenous catheters due to occlusion is 20–69% (Bolton,
2010; Rickard et al., 2010, 2012; Royer, 2003). The failure
rate of central venous catheters due to occlusion ranges
from 15% to 66%, depending on the device, setting and
population (Baskin et al., 2009; Raad et al., 2002, 2003;
Timsit et al., 2011a). Repeated catheter insertions due to
failed catheters require multiple penetrations of the skin
barrier, increase patient discomfort and staff time, and
predispose patients to infection from skin commensals.
Such infections can be life threatening in the acute and
critically ill (Maki et al., 2006; Mermel et al., 2009; Raad
et al., 2007). Therefore, methods that can prolong the
duration of viability of both peripheral and central venous
catheters hold signiﬁcant beneﬁt for patient outcomes and
the quality of organisational care delivered.
The USA’s Centers for Disease Control (CDC) and the
UK’s EPIC3 Guidelines for preventing healthcare associated
infections (HCAIs) only brieﬂy address the issue of vascular
access device patency, and when they do it is in relation to
central venous catheters not peripheral intravenous
catheters. The Catheter Related Bloodstream Infection
(CRBSI) rate in central venous catheters in the USA is
approximately 3% (Maki et al., 2006) whereas central
venous catheter failure rates due to occlusion or thrombo-
sis range from 15 to 66% (Baskin et al., 2009; Raad et al.,
2003, 2002; Timsit et al., 2011a). CRBSI rates in peripheral
intravenous catheters are extremely low (0.1% Maki et al.,
2006). On the other hand, peripheral intravenous catheter
failure rates due to dislodgement, occlusion, inﬁltration or
phlebitis sit at 26% in Australia (Rickard et al., 2012), 38% in
Spain (Chico-Padron et al., 2011) and 53% in the USA
(Bausone-Gazda et al., 2010). Leading professional Asso-
ciations include some guidelines for maintaining vascular
Conclusions: Flushing practices for vascular access device ﬂushing appear to vary widely.
Speciﬁc areas of practice that warrant further investigation include questions about the
efﬁcacy of heparin for central device ﬂushing, increasing adherence to the recommended
10 mL diameter syringe use, increased use of preﬁlled ﬂush syringes, identifying and
standardising optimal volumes and frequency of ﬂushing, and improving documentation
of ﬂush orders and administration.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ciety, 2011; Royal Nurses’ Association of Ontario, 2005).
vels of evidence informing these recommendations
ere limited to level IV or V (i.e. single quasi-experimen-
l clinical/lab study or clinical opinion). Recommenda-
ns about frequency, volume, syringe size or mode
ffered. Local guidelines are found to be similarly lacking
 inconsistent.
The results of research comparing continuous infusion
rsus intermittent ﬂushes to maintain catheter patency
main inconclusive, with studies yielding varied ﬁndings
ernandez et al., 2003; Flint et al., 2005). There are no large
ulti site trials comparing different ﬂushing regimens (i.e.
gular versus PRN; 6 hourly versus daily; 3 mL versus
 mL). Evidence about the use of heparinised ﬂushing
lution versus normal saline or other interventions is also
conclusive (Randolph et al., 1998). Indeed, the optimum
proach to ﬂushing practice is not known, therefore the
consistent nature of ﬂushing recommendations in orga-
sational guidelines is not surprising. Consequently, it is
ely to survey current ﬂushing practice related to
aintenance of peripheral and central venous catheter
tency.
 Aim and objective of study
The aim of this study was to survey a large cohort of
rses and midwives with the objective of increasing our
owledge and understanding of current ﬂushing prac-
es.
. Design
This study employed a descriptive, exploratory design
ing a large cross-sectional survey to gather information
at would address the following research questions:
What are the current peripheral intravenous catheter
ﬂushing practices among nurses and midwives in
Queensland hospitals?
What are the current central venous catheter ﬂushing
practices among nurses and midwives in Queensland
hospitals?
. Sample
The population of registered nurses and midwives in
eensland (Australia) hospitals was accessed through the
eensland Nurses’ Union (QNU) database. There are
proximately 67,000 nurses and midwives registered in
eensland. Of these 49,806 are QNU members, of whom
proximately 70% receive an electronic newsletter. The
U agreed to pass on the survey invitation and link to
ese members via the monthly electronic newsletter for
o consecutive months.
. Survey
A literature search identiﬁed a tool developed speciﬁ-
lly for measuring the ﬂushing practices of nurses that
red for patients who had a central venous catheter
inserted (Sona et al., 2012). This survey was based upon the
original ten-item instrument that was used for a national
survey of critical care nurses drawn from the American
Association of Critical Care Nurses (Sona et al., 2012). The
items and content were based on a literature search that
remains current and had input from clinical experts. The
authors had also tested face and content validity using a
pilot sample and expert panel. Some changes were made to
the original tool for the study conducted in Queensland, in
order to (a) make it applicable to the Australian population
(i.e. vernacular), and (b) be relevant to peripheral
intravenous catheter ﬂushing as well as that of central
venous catheters. The ﬁnal Australian survey had 25 items
(including demographics). The majority of questions
followed a multiple-choice format but did include short
response items. It was designed to take approximately
10 min to complete. The survey was conducted using an
electronic platform with licensed software (LimeSur-
veyTM). All responses were conﬁdential and anonymous.
This survey tool was successfully piloted locally using the
electronic method of delivery before implementation.
2.4. Data collection
Following approval by both hospital and university
based Human Research Ethics Committees (NRS/19/13/
HREC), an invitation to participate in the survey was sent
out for July 2013. A reminder message was sent the
following month in the newsletter to optimise response
rate. Participants were asked to complete the survey on-
line via a web link in the electronically distributed
newsletter.
2.5. Data analysis
Survey data were exported and analysed using PASW
Statistics v.20 (SPSS Inc.). Descriptive statistics were
calculated to summarise demographics and key variables.
Data were presented for the overall sample, and then
broken down into those who reported peripheral intrave-
nous catheter ﬂushing, and those who reported central
venous catheter ﬂushing. There was overlap between the
respondents who replied for the peripheral and central
venous catheter sections of the survey. Cross tabulation
and differences between variables were tested using
Pearson’s chi-square.
3. Results
A total of 1203 surveys were returned, with 1178 con-
taining complete data for further analysis (see Fig. 1). Of
this number, 1068 (91%) respondents cared for patients
with peripheral intravenous catheters and 584 (50%) cared
for patients with central venous catheters. The majority of
respondents were registered nurses (55%) caring for adult
patients (63%) in a metropolitan facility (48%). Respon-
dents represented nurses and midwives from a range of
settings: primary and acute; metropolitan, regional and
remote; neonatal, paediatric, adult. Full occupational
details are presented in Table 1. The broad distribution
of the survey promoted the opportunity to receive
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nd rural settings (35% and 17% respectively), as well as
cross a range of patient populations including paediatric
nd neonatal (7% and 2% respectively). Respondents had a
ange of experience but were represented evenly, with 50%
f respondents having worked in their clinical domain for
ore than six years.
.1. Flushing practice
Data revealed that sodium chloride 0.9% was the most
equent solution used for ﬂushing for both peripheral
atheters (96%) and central catheters (75%) devices. Some
rm of Heparin was used by 25% of respondents in the
entral venous catheter group. The majority of respon-
ents (approximately 60%) reported 10 mL as the most
ommon volume used to ﬂush both peripheral and central
enous catheter, with 5 mL being the next most common
mount. Most respondents used a 10 mL size syringe to
dminister ﬂushes to peripheral catheters (75%) and
entral catheters (82%). Of respondents using syringes of
ss than 10 mL volume, there was a higher incidence (23%)
 the peripheral catheter group than the central catheter
roup (8%). Cross tabulation and correlation analysis
evealed that clinicians from a paediatric/neonatal setting
were more likely to use a smaller syringe (i.e. 2 mL or 5 mL)
to administer a peripheral intravenous catheter ﬂush than
those working in an adult setting (52% and 89% respec-
tively, p < 0.0001). Responses on frequency of ﬂushing
were wide and varied, with the most commonly reported
timings being pre- and post-drug administration only
(Peripheral 23% and Central 21%), and pre- and post-drug
plus 6 hourly administration (Peripheral 23% and Central
22%). Full details of all responses are in Table 2.
Most nurses and midwives reported being aware of an
institutional ﬂushing policy related to peripheral and
central venous catheters (72% and 80% respectively). The
vast majority of respondents manually prepared ﬂushes
for administration, with only a small percentage using
preﬁlled syringes (Peripheral 10% and Central 11%). It is
unknown whether these respondents were referring to
commercially available, sterile pre-ﬁlled ﬂush syringes, or
to manually pre-ﬁlled syringes by themselves or another
practitioner in their institution. Less than half of the
respondents in both groups reported that a medical order
was required for ﬂushing. Chi square testing revealed that
nurses from a paediatric or neonatal setting were more
likely to have an order for ﬂushing and to document
administration of ﬂush, compared with practices in adult
settings (Peripheral 89% and 82% respectively, p < 0.001,
* PIVC – peripheral intravenous cath eter ** Central venous catheter 
n=1178 
Use CVC **584  
Total number  of  re sponses 
(n=1203) 
Incomplete 
demographics  (n=25) 
Use PIVC* 1028 
Union eNews recipients 
n=34,864 (approx  70%) 
Union members 
n=49,806 
Queensland Nurse’s & Midwives 
n=66,364 
Fig. 1. Sample ﬂow diagram.
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S. Keogh et al. / International Journal of Nursing Studies 52 (2015) 1678–16851682d Central 84% and 66% respectively, p < 0.001). More
an half reported that they document ﬂush administra-
n in either the medication chart or ﬂuid balance chart.
third of all respondents reported that their ﬂush
ministrations were rarely documented. Details of these
aracteristics are presented in Table 3.
 Discussion
The study achieved its aim to generate a cross-sectional
apshot of nursing and midwifery vascular access device
shing practice across Queensland. This is the ﬁrst
stematic investigation undertaken into peripheral intra-
nous catheter ﬂushing practice anywhere in the world,
d only the second study to our knowledge focussing on
ntral venous catheters. Like Sona and colleagues’ work
m the USA, we found a wide variation in practitioners’
sponses for ﬂushing solution, frequency and volumes.
eir respondents reported a slightly higher use of heparin
lution for central venous catheter ﬂushing (33%, 213/
2) compared to our ﬁnding of 25%, and reported eight
urly standardised ﬂushing as the most common practice,
mpared to our ﬁnding of six hourly plus pre/post-drug
ministration.
Most respondents in this study reported that their
ndard ﬂush solution was sodium chloride 0.9% using
 mL of solution in a 10 mL syringe. Paediatric and
onatal practitioners were more likely to use smaller
ringes. Flushing syringes chosen were either 2 mL or
L sizes for 89% of neonatal nurses and 54% of paediatric
rses. This is probably related to the general use of
implies a lack of appreciation for the increase in pressure
per square inch (PSI) associated with the properties of
smaller size syringes. The use of reduced pressure for ﬂush
delivery through a syringe with a larger gauge such as the
standard 10 mL syringe is recommended to optimise ﬂush
outcomes and minimise damage to the vein (Hadaway,
2006; Macklin, 1999; Perucca, 2010). These recommenda-
tions are largely derived from physics principles, and have
not been and possibly could not be explicitly tested in
clinical trials. In recent times, commercially prepared
preﬁlled ﬂush syringes have become available, which
negate the potential for operators to make an incorrect
choice of a smaller size syringe, since they are produced in
diameters consistent with a 10 mL syringe, but in 3, 5 and
10 mL volumes. A small, single site trial of different
ﬂushing frequencies (twice daily versus once daily)
demonstrated similar risk of peripheral intravenous
catheter failure (12.1% versus 9.5%). However, the sample
was a select paediatric population (no infusion therapy or
intravenous antibiotics). Additionally, the overall risk of
failure was noted to be very low compared to other studies
(8.7%, n = 497) and this was possibly related to the use of
pre-ﬁlled ﬂush syringes across both groups (Schreiber
et al., 2015). One non-randomised study suggests pre-ﬁlled
ﬂush syringes can reduce bloodstream infections, over
ble 1
cupational proﬁle of nursing and midwifery respondents.
Overall
n = 1178
PIVCa
n = 1068
CVCb
n = 584
ospital type
etropolitan 562 (48%) 523 (49%) 336 (57%)
egional 414 (35%) 375 (35%) 202 (35%)
ural/remote 202 (17%) 170 (16%) 46 (8%)
atient type
dult 743 (63%) 670 (63%) 392 (67%)
ombined 329 (28%) 293 (27.4%) 124 (21%)
aediatric 77 (7%) 76 (7.1%) 59 (10%)
eonatal 29 (2%) 29 (3%) 9 (2%)
osition
N 651 (55%) 602 (56%) 352 (60%)
N 317 (27%) 297 (28%) 169 (29%)
NC/NUM 89 (8%) 74 (7%) 42 (7%)
idwife 59 (5%) 51 (5%) 7 (1%)
EN 44 (4%) 32 (3%) 8 (1%)
evel 8+ 14 (1%) 11 (1%) 5 (1%)
N 4 (0.3%) 1 (0.1%) 1 (0.2%)
ears in nursing
2 years 236 (20%) 210 (20%) 100 (17%)
–5 years 362 (31%) 332 (30%) 181 (31%)
–10 years 231 (19%) 211 (20%) 122 (21%)
10 years 349 (30%) 315 (30%) 181 (31%)
PIVC – peripheral intravenous catheter.
Central venous catheter.
Table 2
Data on IVD ﬂushing practice from nursing and midwifery respondents.
PIVCa
n = 1068
CVCb
n = 584
Flush solution
NaCl 0.9% 987 (96%) 423 (75%)
HepSaline 33 (3%) 102 (18%)
Other 8 (1%) 41 (7%)
Incomplete/missing data 40 (4%) 18 (3%)
Flush volume
2 mL 55 (5%) 23 (4%)
5 mL 324 (31%) 104 (18%)
10 mL 589 (57%) 348 (61%)
20 mL – 40 (7%)
Other 60 (%) 51 (10%)
Incomplete/missing data 40 (4%) 18 (3)
Syringe size
2 mL 40 (4%) 12 (2%)
5 mL 192 (19%) 37 (7%)
10 mL 768 (75%) 465 (82%)
20 mL – 34 (6%)
Other 28 (2%) 18 (3%)
Incomplete/missing data 40 (4%) 18 (3%)
Frequency of ﬂush
Pre/post drug admin only 237 (23%) 117 (21%)
4/24 only 45 (4%) 18 (3%)
4/24 + pre/post drug admin 94 (9%) 52 (9%)
6/24 only 139 (13%) 65 (11%)
6/24 + pre/post drug admin 238 (23%) 126 (22%)
8/24 only 69 (7%) 28 (5%)
8/24 + pre/post drug admin 129 (13%) 66 (12%)
Daily only 26 (2%) 18 (3%)
Daily + pre/post drug admin 51 (5%) 76 (14%)
Incomplete/missing data 40 (4%) 18 (3%)
a PIVC – peripheral intravenous catheter.
b Central venous catheter.anually ﬁlled syringes (Bertoglio et al., 2013).aller volumes for ﬂushing in these populations. This m
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S. Keogh et al. / International Journal of Nursing Studies 52 (2015) 1678–1685 1683Reported use of preﬁlled syringes by participants was
inimal in this survey (Peripheral 10% and Central 11%).
e did not ask respondents who was pre-ﬁlling the
yringes, which may have been manufacturer-prepared
terile syringes which are clearly labelled as to contents
nd with 10 mL diameters, or syringes pre-prepared by
e nurse/midwife themselves, or by another colleague.
he latter practice would be concerning due to the risk of
icrobial contamination and potential lack of labelling.
A small but substantial number of practitioners caring
r central venous catheters (25%) reported using some
rm of Heparin as a ﬂush solution. The reason for this is
ot known. Currently the Queensland State policy for
entral venous catheter ﬂushing recommends Sodium
hloride 0.9% as the preferred ﬂush or infusion solution
ueensland Health, 2011). A number of studies have
hown Heparin to support the growth of organisms in
olution and in bioﬁlm (Raad et al., 2002, 2003; Shah et al.,
002; Shanks et al., 2005). Both experimental and cohort
tudies suggest a close relationship between catheter
rombosis and infection, indicating a need for Heparin
imsit et al., 2011a,b). Other clinical trial results
emonstrated that Heparin might reduce CRBSI (Abdelkeﬁ
t al., 2005; Birch et al., 2010; Pierce et al., 2000). The latter
tudies reported that the Heparin solution also contained a
reservative with antimicrobial activity, and it is therefore
nclear whether the decrease in CRBSI rate would be due
 decreased thrombus formation or the preservative, or
oth (Timsit et al., 2011a). The potential beneﬁts of
eparin ﬂushes and/Heparin-coated catheters must be
alanced against the risk of Heparin-induced thrombocy-
penia, a rare but serious adverse reaction (Timsit et al.,
011b).
There is currently little evidence informing the
ecommendations for either the volume or frequency
required for a vascular access device ﬂush. Generally,
organisational and industry guidelines recommend ‘‘a
minimum ﬂush volume equal to twice the internal volume
of the catheter system, which includes the catheter,
extension set, and/or needleless injection system added
to the catheter hub’’ (Infusion Nursing Society, 2011). This
usually translates to 1–3 mL for a peripheral intravenous
catheter and 5–10 mL for central venous catheter, with a
volume of 20 mL preferred after obtaining a blood sample
(Infusion Nursing Society, 2011). Such recommendations
were generally reﬂected in the practice reported by
participants for central venous catheters, but ﬂush
volumes larger than 3 mL were commonly reported for
peripheral intravenous catheters in this survey, suggesting
a widespread lack of knowledge of these recommendations
for these devices. Similar to lack of recommendations
regarding ﬂush volumes, there are few studies evaluating
the effect of ﬂushing frequency on patient outcomes, with
no rigorous trials to inform practice for either of these two
variables (Campbell et al., 2005). This lack of evidence to
inform clinicians was apparent from the survey results,
which revealed an unacceptable variation in the array of
ﬂushing practices amongst respondents caring for patients
with these devices.
Respondents in this study were largely aware of their
local Queensland Health policy on vascular access device
ﬂushing (Peripheral 72% and Central 80%). The policy
allows for nurse-initiated ﬂushing without a speciﬁc
medical order, but there is no recommendation for
documentation of these ﬂushes, and respondents reported
poor and varied documentation of ﬂushing. A record of
vascular access device ﬂushes given would not only
demonstrate the evaluation and conﬁrmation of device
assessment and patency but also record the patient’s ﬂuid
balance. An exception was noted, in that respondents from
paediatric or neonatal settings were more likely to
document ﬂush administration. This reﬂects the practice
of maintaining a strict ﬂuid balance record in these
settings.
This study has principally highlighted and conﬁrmed
the variation and gaps in vascular access device ﬂushing
practice and knowledge. In lieu of much needed trial
research, clinicians and organisations could make efforts to
standardise and streamline ﬂushing practice in order to
minimise inconsistencies and optimise documentation.
The USA’s Infusion Nursing Society, Canada’s Registered
Nurses’ Association Ontario, and many local guidelines
recommend: initial aspiration of blood to ascertain
vascular access device patency; a minimum of pre- and
post-drug administration ﬂushing; use of single dose
preﬁlled ﬂush syringes to minimise device and solution
contamination and incorrect syringe use; volume deter-
mined by size of catheter and patient; and use of a pulsatile
technique (Infusion Nursing Society, 2011; Registered
Nurses’ Association Ontario, 2005).
The strengths of this study were its large number of
respondents and grounding in the current literature.
Generalisability of results is somewhat limited, since the
respondents did not include the total workforce of the
State of Queensland. Nonetheless, the large absolute
numbers and heterogeneous sample does suggest that a
able 3
ata on organisational recommendations and ﬂushing practice from
ursing and midwifery respondents.
PIVCa
n = 1068
CVCb
n = 584
Flushing policy
Yes 742 (72%) 451 (80%)
No 82 (8%) 28 (5%)
Unsure 204 (19%) 87 (15%)
Incomplete/missing 40 (4%) 18 (3%)
Preparation
Manual 915 (89%) 501 (88%)
Preﬁlled 108 (10%) 64 (11%)
Incomplete/missing data 45 (4%) 19 (3%)
Flush order
Yes 396 (38%) 267 (47%)
No 598 (58%) 273 (48%)
Unsure 30 (3%) 24 (5%)
Incomplete/missing data 44 (4%) 20 (3%)
Flush documented
Medication chart 469 (46%) 282 (50%)
IV Fluid chart 86 (8%) 65 (11%)
Not documented 357 (35%) 164 (29%)
Incomplete/missing data 146 (14%) 75 (12%)
a PIVC – peripheral intravenous catheter.
b Central venous catheter.
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S. Keogh et al. / International Journal of Nursing Studies 52 (2015) 1678–16851684asonably representative cross-section of this group was
mpled. The absolute denominator is not available, but
sed on the population details, the approximate response
te was 3.5%. Furthermore, observational designs like
oss-sectional studies cannot test any direct cause and
fect relationship and therefore cannot inform or make
m recommendations for practice. Although cross-sec-
nal designs provide only a ‘‘once off’’ measurement and
 not allow for understanding of changes in practice over
e, this survey could be repeated some years in the
ture to assess for practice evolution. The value of the
dy’s results lies in the summary of current practice
d its ability to inform future trial work to improve
shing practice and patient care.
 Conclusion
This survey highlights a number of inconsistencies in
actice that reﬂect the current lack of evidence in the area
 vascular access device ﬂushing. Results of the survey
ve clariﬁed current nursing practice related to periph-
al central venous ﬂushing. The study has helped to
entify gaps in practice and research, and lay foundations
r the conduct of randomised controlled trials to generate
idence related to peripheral central venous ﬂushing.
gorous research is urgently required to establish the
timal ﬂushing solution, volume, frequency, and mecha-
sm that will prevent vascular access device malfunction,
us optimising patient comfort and clinical outcomes.
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